West Pharmaceutical Services Inc (NYSE:WST)
| 235.91 Delayed Data As of 3:22pm ET |  +0.02 / +0.01%Today’s Change | 206.19 Today|||52-Week Range 475.00 | -49.70% Year-to-Date |
Latest WST News | Press Releases
No recent news for West Pharmaceutical Services Inc.
Today’s Trading
| Previous close | 235.89 |
| Today’s open | 233.99 |
| Day’s range | 233.59 - 237.40 |
| Volume | 465,895 |
| Average volume (3 months) | 605,297 |
| Market cap | $18.1B |
Data as of 3:22pm ET, 12/08/2022
Growth & Valuation
| Earnings growth (last year) | +89.88% |
| Earnings growth (this year) | -4.86% |
| Earnings growth (next 5 years) | +15.06% |
| Revenue growth (last year) | +31.86% |
| P/E ratio | 28.6 |
| Price/Sales | 12.64 |
| Price/Book | 7.76 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| SAUHFStraumann Holding AG | -3.80 | -3.30% |
| ABMDABIOMED Inc | +2.78 | +0.74% |
| PODDInsulet Corp | +0.50 | +0.16% |
| TFXTeleflex Inc | +3.79 | +1.58% |
Data as of 3:22pm ET, 12/08/2022
Financials
| Next reporting date | February 16, 2023 |
| EPS forecast (this quarter) | $1.37 |
| Annual revenue (last year) | $2.8B |
| Annual profit (last year) | $661.8M |
| Net profit margin | 23.38% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Exton, Pennsylvania |
Forecasts
